首页> 外文OA文献 >The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice
【2h】

The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice

机译:PRO-AGE研究:基于一般实践的国际老年人健康风险评估的随机对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: This paper describes the study protocol, the recruitment, and base-line data for evaluating the success of randomisation of the PRO-AGE (PRevention in Older people-Assessment in GEneralists' practices) project. METHODS/DESIGN: A group of general practitioners (GPs) in London (U.K.), Hamburg (Germany) and Solothurn (Switzerland) were trained in risk identification, health promotion, and prevention in older people. Their non-disabled older patients were invited to participate in a randomised controlled study. Participants allocated to the intervention group were offered the Health Risk Appraisal for Older Persons (HRA-O) instrument with a site-specific method for reinforcement (London: physician reminders in electronic medical record; Hamburg: one group session or two preventive home visits; Solothurn: six-monthly preventive home visits over a two-year period). Participants allocated to the control group received usual care. At each site, an additional group of GPs did not receive the training, and their eligible patients were invited to participate in a concurrent comparison group. Primary outcomes are self-reported health behaviour and preventative care use at one-year follow-up. In Solothurn, an additional follow-up was conducted at two years. The number of older persons agreeing to participate (% of eligible persons) in the randomised controlled study was 2503 (66.0%) in London, 2580 (53.6%) in Hamburg, and 2284 (67.5%) in Solothurn. Base-line findings confirm that randomisation of participants was successful, with comparable characteristics between intervention and control groups. The number of persons (% of eligible) enrolled in the concurrent comparison group was 636 (48.8%) in London, 746 (35.7%) in Hamburg, and 1171 (63.0%) in Solothurn. DISCUSSION: PRO-AGE is the first large-scale randomised controlled trial of health risk appraisal for older people in Europe. Its results will inform about the effects of implementing HRA-O with different methods of reinforcement.
机译:背景:本文描述了用于评估PRO-AGE(老年人的参与度-普通科医生实践中的评估)项目随机化的研究方案,募集和基线数据。方法/设计:一组伦敦(英国),汉堡(德国)和索洛图恩(瑞士)的全科医生(GPs)接受了风险识别,健康促进和老年人预防的培训。他们的非残疾老年患者被邀请参加一项随机对照研究。分配给干预组的参与者获得了针对老年人的健康风险评估(HRA-O)仪器,该仪器采用了针对特定地点的强化方法(伦敦:电子病历中的医生提醒;汉堡:一组会议或两次预防性上门拜访;索洛图恩(Solothurn):在两年期间内每六个月进行一次预防性家访。分配给对照组的参与者得到常规护理。在每个站点,另外一组全科医生没有接受培训,他们的合格患者被邀请参加同期比较组。主要结果是在一年的随访中自我报告的健康行为和预防性护理的使用。在索洛图恩,两年后又进行了一次随访。同意参加随机对照研究的老年人(占合格人口的百分比)在伦敦为2503(66.0%),在汉堡为2580(53.6%),在索洛图恩为2284(67.5%)。基线发现证实参与者的随机分组是成功的,干预组和对照组之间具有可比的特征。同时参加比较组的人数(符合资格的人数)在伦敦为636(48.8%),在汉堡为746(35.7%),在索洛图恩为1171(63.0%)。讨论:PRO-AGE是欧洲第一项针对老年人的健康风险评估的大型随机对照试验。其结果将告知采用不同加固方法实施HRA-O的效果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号